Home › Cholesterol › Texas
Cholesterol clinical trials in Texas
6 studies for Cholesterol are looking for participants at sites in Texas.
Cities in Texas
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
- PharmaTex Research, Amarillo
- Amarillo Heart Clinical Research Institute, Inc., Amarillo
- Austin Heart, Austin
- and 8 more
RecruitingPhase 4
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT06909565A Phase III Study to Assess the Effect of FDC Laroprovstat/Rosuvastatin Compared With Laroprovstat, Rosuvastatin and Placebo on LDL-C in LLT-naïve Patients.
- Research Site, Houston
- Research Site, Houston
- Research Site, Houston
- and 3 more
RecruitingPhase 3
Ages 18 to 130 · All sexes · Updated Sep 10, 2026 · NCT07619131A Study to Evaluate the Pharmacodynamics of a Combination of QCZ484 and Inclisiran in Participants With Hypertension and Concomitant Hypercholesterolemia
- Synergy Group Medical LLC, Houston
- Synergy Group Medical LLC, Houston
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Jul 30, 2026 · NCT07610278A Study to See How Safe and Effective Alirocumab is When Given Weekly to Adult Participants Who Have Hypercholesterolemia
- Velocity Clinical Research Dallas, Dallas
- Valley Institute of Research, Rockwood Medical Clinic, Fort Worth
- Be Well Clinical Studies - Round Rock, Round Rock
- and 3 more
RecruitingPhase 2
Ages 18 to 80 · All sexes · Updated Jul 22, 2026 · NCT07477704Multicomponent Intervention Study- Blood Donors With High Cholesterol
- UT Southwestern Medical Center, Dallas
Recruiting
Ages 18 to 75 · All sexes · Updated Mar 17, 2026 · NCT05693701Alirocumab in Patients on a Stable Dialysis Regimen
- Baylor Soltero CV Research, Dallas
RecruitingPhase 3
Ages 18 to 80 · All sexes · Updated Feb 12, 2020 · NCT03480568From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.